257 related articles for article (PubMed ID: 2991832)
1. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
Barnes RB; Roy S; Lobo RA
Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
[TBL] [Abstract][Full Text] [Related]
2. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
Lobo RA; McCormick W; Singer F; Roy S
Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
[TBL] [Abstract][Full Text] [Related]
3. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
4. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
[TBL] [Abstract][Full Text] [Related]
5. The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women.
Soma MR; Osnago-Gadda I; Paoletti R; Fumagalli R; Morrisett JD; Meschia M; Crosignani P
Arch Intern Med; 1993 Jun; 153(12):1462-8. PubMed ID: 8390232
[TBL] [Abstract][Full Text] [Related]
6. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy.
Luciano AA; Turksoy RN; Carleo J; Hendrix JW
Obstet Gynecol; 1988 Jan; 71(1):39-43. PubMed ID: 2827082
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
[TBL] [Abstract][Full Text] [Related]
8. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
[TBL] [Abstract][Full Text] [Related]
9. Lipid changes after hormone replacement therapy for menopause.
Kable WT; Gallagher JC; Nachtigall L; Goldgar D
J Reprod Med; 1990 May; 35(5):512-8. PubMed ID: 2112606
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
Darling GM; Johns JA; McCloud PI; Davis SR
N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481
[TBL] [Abstract][Full Text] [Related]
11. [Postmenopausal women: changes in plasma lipids with different estrogen replacement therapies].
Blumel JE; Brandt A; Garabagno A; Cubillos M; Lozano A
Rev Med Chil; 1990 Apr; 118(4):382-7. PubMed ID: 2133147
[TBL] [Abstract][Full Text] [Related]
12. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
Hargrove JT; Maxson WS; Wentz AC; Burnett LS
Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin.
Miller VT; Muesing RA; LaRosa JC; Stoy DB; Fowler SE; Stillman RJ
Obstet Gynecol; 1994 Feb; 83(2):173-9. PubMed ID: 8290177
[TBL] [Abstract][Full Text] [Related]
14. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group.
Lobo RA; Pickar JH; Wild RA; Walsh B; Hirvonen E
Obstet Gynecol; 1994 Dec; 84(6):987-95. PubMed ID: 7970483
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
[TBL] [Abstract][Full Text] [Related]
16. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
17. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
[TBL] [Abstract][Full Text] [Related]
18. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
19. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
[TBL] [Abstract][Full Text] [Related]
20. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women.
Lindheim SR; Notelovitz M; Feldman EB; Larsen S; Khan FY; Lobo RA
Obstet Gynecol; 1994 Feb; 83(2):167-72. PubMed ID: 8290176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
